The QualityStocks Daily Monday, October 14th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(TVGN) $1.0900 +187.14%

QualityStocks(VERB) $12.5300 +58.41%

Premium Stock Alerts(RANI) $3.1800 +57.43%

The QualityStocks Daily Stock List

Dogness International (DOGZ)

TradersPro, QualityStocks, MarketClub Analysis, StreetInsider, TopPennyStockMovers, StockMarketWatch, Schaeffer's, InvestorPlace and FreeRealTime reported earlier on Dogness International (DOGZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dogness International Corp. (NASDAQ: DOGZ) is focused on designing, manufacturing and selling smart and fashionable products for pets.

The firm has its headquarters in Dongguan, the People’s Republic of China and was incorporated in 2003 by Shilong Chen. The firm serves consumers around the globe.

The company’s objective is to build the future of pet commerce by innovating its traditional product line while leveraging its proven research and development capabilities to gain leadership in pet Internet of Things. It produces high-quality harnesses, collars and leashes that are comfortable, beautiful and designed to ensure pet owners’ peace of mind and pet safety. The company operates through its subsidiaries.

The enterprise produces products in Special function, Holiday, LED, Luxury, Elegance, Cat and Classic series. They include pet harnesses, pet collars, retractable leashes, lanyards and pet leashes; pet belt ribbons, elastic belts, laces, high-grade textiles and computer jacquard ribbons; gift suspenders; pet charms and mouth covers; climbing hooks; pet shampoos; and intelligent pet products like pet water fountains, app-controlled pet feeders and smart pet toys. It also provides the anti-shock leash, the H2 smart harness and the C2 smart collar. The enterprise has designed its smart collars to allow owners to find their dogs easily. It provides its products to retailers and wholesalers.

The company recently announced that it would be expanding the availability of its smart pet products online and in stores, building on its existing supplier relationships. This move will help extend the company’s consumer reach, which will not only bring in more revenue into the company but also drive its growth.

Dogness International (DOGZ), closed Monday's trading session at $45.62, up 13.3698%, on 196,981 volume. The average volume for the last 3 months is 91,300 and the stock's 52-week low/high is $2.785/$46.92.

QS Energy, Inc. (QSEP)

QualityStocks, MarketBeat, RedChip, StocksEarning, TopPennyStockMovers and PoliticsAndMyPortfolio reported earlier on QS Energy, Inc. (QSEP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Established in 1998, QS Energy, Inc. is  a developer of integrated technology solutions for the energy industry. It develops and commercializes energy efficiency technologies that help in meeting rising global energy demands, improving the economics of oil extraction and transport, and lessening greenhouse gas emissions. The Company’s Intellectual Property  (IP) portfolio includes 48 domestic and worldwide patents and patents pending. These have undergone development in combination with, and exclusively licensed from, Temple University. OTCQB-listed, QS Energy is based in Tomball, Texas.

QS Energy’s AOT™ (Applied Oil Technology) is a group of commercial crude oil pipeline flow assurance products designed to undergo installation at pipeline pump stations in the upstream, gathering, and midstream sectors. AOT™ is an integrated system. It improves vital operational efficiencies for pipeline operators worldwide. The Company has its new strategic plan. The core mission of this plan is to expedite market adoption of its AOT™  technology.

AOT™ is an industrial hardware system and is completely fabricated in the U.S. AOT™  lowers the viscosity of unrefined oil utilizing low wattage electrical fields (electrorheology) to improve flow while in transit through pipelines. AOT™ technology delivers performance that can be measured in each of the areas of importance in the movement hydrocarbon stream - from reservoir to the point of sale.

QS Energy’s  AOT™ stand-alone or supplemental pipeline solutions increase flow rates. The Company’s solutions also reduce power consumption; optimize flow assurance; enhance pipeline integrity; and prevent bottlenecks. QS Energy is now positioned to complete its development from research and development (R&D) to commercialization.

QS Energy, Inc. (QSEP), closed Monday's trading session at $0.12, up 20%, on 861,072 volume. The average volume for the last 3 months is 460,953 and the stock's 52-week low/high is $0.0262/$0.1497.

American Lithium Corp. (AMLI)

InvestorPlace, The Night Owl, On Options, iDigital Market, DividendStocks and bullseyeoptiontrading reported earlier on American Lithium Corp. (AMLI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Lithium Corp. (NASDAQ: AMLI) engages in the identification, acquisition, exploration for, and development of lithium deposits in the Americas. An exploration stage company, it is exploring and developing the TLC Project situated in the highly prospective Esmeralda lithium district in Nevada. The Company formerly went by the name Menika Mining Ltd. It changed its name to American Lithium Corp. in April of 2016. Incorporated in 1974, American Lithium is based in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

The TLC Project is close to infrastructure, 3.5 hours south of the Tesla Gigafactory. It is in the same basinal environment as Albemarle's Silver Peak lithium mine and several advancing deposits and resources. These include Ioneer Ltd.'s (formerly Global Geoscience) Rhyolite Ridge and Cypress Development Corp.'s Clayton Valley project.

Currently, American Lithium holds a considerable land position consisting of greater than 4,000 acres at its TLC Project near Tonopah, Nevada, one of the most promising and underdeveloped lithium sedimentary basins in North America. Its recent drill program produced core samples up to 2,285 ppm lithium with many samples more than 1,000 ppm lithium.

Near surface sampling has shown as high as 1,690 ppm of lithium and an average 760 ppm lithium to-date. Initial production tests have shown the regional mineralization can result in 90 percent extraction in minutes instead of days or months in comparison to traditional lithium extraction techniques.

American Lithium Corp. (AMLI), closed Monday's trading session at $1.11, up 19.5992%, on 2,344,446 volume. The average volume for the last 3 months is 23.281M and the stock's 52-week low/high is $0.3226/$1.30.

Cleanspark Inc. (CLSK)

MarketClub Analysis, INO Market Report, QualityStocks, Schaeffer's, TradersPro, MarketBeat, Early Bird, Kiplinger Today, StockMarketWatch, Zacks, InvestorPlace, OTCtipReporter, InvestorsUnderground, Penny Pick Finders, PennyStockScholar, Premium Stock Alerts, Profitable Trader Authority, PennyStockProphet, StocksEarning, 360 Wall Street, Investment House, Tim Bohen, HotOTC, FreeRealTime, StockOnion, Buzz Stocks, BUYINS.NET and Investors Underground reported earlier on Cleanspark Inc. (CLSK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CleanSpark Inc. (NASDAQ: CLSK) (BMV: CLSK) is a sustainable Bitcoin mining and energy technology firm that is engaged in the provision of bitcoin mining and energy technology solutions.

The firm has its headquarters in Henderson, Nevada and was incorporated in 1987, on October 15th by S. Matthew Schultz. Prior to its name change in November 2016, the firm was known as Stratean Inc. It operates as part of the software-application industry, under the technology sector. The firm serves consumers in the United States.

The company operates through the Digital currency mining, Energy and Other business activities. Its digital currency segment operates the CleanBlok Inc. and ATL lines of business while its Energy segment operates the Solar Watt Solutions, GridFabric, CleanSpark Critical Power Systems Inc. and CleanSpark LLC lines of business. On the other hand, the Other activities segment includes CSRE Properties LLC, ATL Data Centers LLC and p2kLabs Inc.

The enterprise, which mines for bitcoin, also offers design and software, engineering, open automated demand response, custom hardware, solar and energy storage solutions for distributed energy systems and microgrids to commercial, military and residential customers. It also provides mVoult and mPulse, which are control platforms that allow for the integration and optimization of more than one energy source. This is in addition to providing software development and other technology-based consulting services.

The company recently expanded its capacity to mine bitcoin through the acquisition of new Whatsminer M30S machines. This move puts the company in an excellent position to grow its mining capacity, which will positively influence its revenues as well as its growth.

Cleanspark Inc. (CLSK), closed Monday's trading session at $10.81, up 12.7216%, on 34,798,116 volume. The average volume for the last 3 months is 19.021M and the stock's 52-week low/high is $3.46/$24.72.

Serve Robotics, Inc. (SERV)

MarketBeat, InvestorPlace, MarketClub Analysis, INO.com Market Report, QualityStocks, Premium Stock Alerts, Zacks, StreetInsider, Timothy Sykes, SmallCapVoice, The Street, Ross Givens, Marketbeat.com, Schaeffer's, 360 Wall Street, Outsider Club, MarketClub Options, Tim Bohen, Streetwise Reports, StreetAuthority Daily, TradersPro, Trades Of The Day, WealthMakers, Early Bird, BUYINS.NET and Barchart reported earlier on Serve Robotics, Inc. (SERV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Serve Robotics, Inc. (NASDAQ: SERV) is a company that specializes in the design, development and operation of low-emission robots which make food deliveries to people in public spaces within the U.S.

The company was incorporated in December, 2020 and has its headquarters in Redwood City, California. It operates in the specialty industrial machinery industry, under the industrials sector. Serve Robotics spun off from Uber and became an independent firm in 2021. Prior to its name change in 2023, the company was called Patricia Acquisition Corp.

The enterprises leverages artificial intelligence to put into operation self-driving robots that make sidewalk deliveries of food, groceries and other parcels to customers located within public spaces. The company has a growing client list that includes major entities, such as Uber Eats as well as 7-Eleven. The company is poised for massive growth due the high rate at which wage bills are growing, shortages of labor, and new laws setting up new classifications of workers. The advancements made in AI, cheaper and faster compute, cheaper data connectivity and cheaper sensor technology are tailwinds that support the growth of the robotics industry.

Serve Robotics is committed to growing its institutional client base and has signed a contract to deploy 2000 delivery robots to serve Uber Eats. The company has plans to expand its operations into new markets like Dallas, San Diego and Vancouver, among others after successful pilot projects in Los Angeles, California.

The company plans to avail multi-modal autonomous deliveries using not only autonomous urban robots but also autonomous vehicles and drones. These different modes are tailored to meet various needs, such as serving clients whose location is distant. Having completed its listing on NASDAQ in April 2024, Serve Robotics is poised to attract additional investment and serve more customers, which will benefit the company and its shareholders.

Serve Robotics, Inc. (SERV), closed Monday's trading session at $8.92, up 2.765%, on 4,848,146 volume. The average volume for the last 3 months is 5.576M and the stock's 52-week low/high is $1.77/$37.00.

Salesforce Inc. (CRM)

The Street, InvestorPlace, Kiplinger Today, Schaeffer's, MarketClub Analysis, Investopedia, MarketBeat, All about trends, StreetInsider, Zacks, StocksEarning, The Online Investor, Trades Of The Day, StockEarnings, StreetAuthority Daily, Early Bird, FreeRealTime, Daily Trade Alert, Barchart, Market Intelligence Center Alert, Money Morning, Cabot Wealth, INO.com Market Report, TipRanks, Marketbeat.com, Money Wealth Matters, Wealth Insider Alert, Money and Markets, Louis Navellier, Street Insider, TopStockAnalysts, internetnews, Daily Wealth, ProfitableTrading, Top Pros' Top Picks, SmarTrend Newsletters, GorillaTrades, PROFIT CONFIDENTIAL, InvestmentHouse, Stansberry Research, The Motley Fool, AllPennyStocks, QualityStocks, Investors Alley, Wyatt Investment Research, TradingMarkets, Super Stock Investor, Trading Concepts, Daily Profit, FeedBlitz, The Wealth Report, InvestorGuide, StrategicTechInvestor, Uncommon Wisdom, Darwin Investing Network, Trading Tips, MarketWatch, TheStockAdvisors, Investment House, CNBC Breaking News, Investment Insights Report, The Night Owl, Stock Tips Network, YOLOTraderAlerts, The Trading Report, Millennium-Traders, Insider Wealth Alert, INO Market Report, Stockhouse, Market Intelligence Center, IT News Daily, InvestorsObserver Team, Trading Markets, FNNO Newsletters, Investing Daily, InsiderTrades, Chaikin PowerFeed, Greenbackers, internet, The Stock Enthusiast, The Best Newsletters, The Street Report, Investment U, StockTwits, Daily Markets, Wall Street Daily, MarketTamer, SmallCapVoice, Earnings360, Dynamic Wealth Report, DividendStocks, Dividend Opportunities, BUYINS.NET, Investing Signal, Inside Trading, SureMoney, The Weekly Options Trader, The Growth Stock Wire, The Stock Dork, The Wall Street Transcript, Eagle Financial Publications, WStreet Market Commentary, Investor Guide, Investor Update, Wealth Daily, CustomerService, equities Canada, Todd Horwitz, Options Elite, Smart Investing Society, Trading with Larry Benedict, TradingAuthority Daily, SmartMoneyTrading, Bellwether Report, TheStockAdvisor, Jim Cramer, TheOptionSpecialist, Equities.com, Brainy Brands Company Alerts, Average Joe Options, Inside Investing Daily, Buttonwood Research, Hit and Run Candle Sticks, Chaikin Analytics, Damn Good Penny Picks, PennyOmega, Traders For Cash Flow, StockMarketWatch, StockOnion, Stocks That Move, Stocks To Watch, Stocktwiter, StreetAuthority Financial, TheTradingReport, Penny Pick Finders, Trader Prep, Rick Saddler, TradersPro, Trading For Keeps, TradingTips, Vantage Wire, Wall Street Greek, Wallstreetlivechat, Wealthpire Inc., Trade of the Week, 24/7 Trader, Investiv, InvestorsUnderground, iStockAnalyst, Jon Markman's Pivotal Point, Leeb's Market Forecast, Market Authority, Market FN, SmallCap Network, OTCtipReporter, SiliconValley, Penny Stock Buzz and PennyStockProphet reported earlier on Salesforce Inc. (CRM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Prior studies have determined that men are more likely to develop glioblastoma in comparison to women. These studies have also shown these tumors are usually more aggressive in males as compared to women.

Now scientists are using artificial intelligence (AI) to uncover risk factors that may help clinicians predict which tumors might grow more quickly and the differences between the sexes.

For their study, the researchers examined digital images of tumor samples, searching for patterns that could help predict how quickly a tumor could grow and, in turn, how long a patient could survive with the illness. The outcome dictates the treatments to be administered and the patient’s quality of life following diagnosis.

Normally, patients with glioblastoma don’t live long following their diagnosis. The current median survival for this very aggressive cancer form is 15 months post-diagnosis.

Professor Pallavi Tiwari, who specializes in biomedical engineering and is a radiology professor, and Ruchika Verma, a former graduate student, led the study. To determine the outcome, the researchers designed an artificial intelligence model that could pick out any pattern on thin slices of samples of tumors that may not be apparent to the naked human eye.

They then trained the model using data from more than 250 studies of patients with glioblastoma, making it easier for the model to recognize the unique characteristics of the tumors. These include the abundance of specific types of cells. In addition, they trained the model to pick out patterns between these characteristics and the survival time for patients, while taking their gender into account.

This allowed the model to determine that in males, the presence of pseudopalisading cells was linked to more aggressive tumors. In women, higher-risk characteristics included tumors invading healthy tissues. The model was also able to recognize characteristics that could translate into worse prognoses for both women and men. These findings could assist in the development of more individualized care for patients with glioblastoma.

Verma explained that with this discovery, they hoped to encourage additional research into the underlying biological differences observed in the tumors while inspiring new approaches for personalized therapy.

Tiwari and her colleagues are already using artificial intelligence to analyze breast and pancreatic cancers, focused on improving patient outcomes.

The researchers reported their findings in the “Science Advances” journal. Other researchers involved in the study included Tyler J. Alban, Prerana Parthasarathy, Mojgan Mokhtari, Paula Toro Castano, Mark L. Cohen, Justin D. Lathia and Manmeet Ahluwalia.

In addition to the use of AI in the healthcare sector, the technology is also finding utility in the business field. Enterprises such as Salesforce Inc. (NYSE: CRM) are innovating solutions that promise to revolutionize the way business operations are conducted.

Salesforce Inc. (CRM), closed Monday's trading session at $291.64, up 1.2287%, on 3,642,540 volume. The average volume for the last 3 months is 36.344M and the stock's 52-week low/high is $193.68/$318.715.

Marathon Digital Holdings Inc. (MARA)

MarketClub Analysis, Schaeffer's, InvestorPlace, QualityStocks, INO Market Report, StockMarketWatch, MarketBeat, StockEarnings, StocksEarning, TradersPro, Early Bird, Zacks, Investors Underground, InvestorsUnderground, BUYINS.NET, The Online Investor, Lebed.biz, Trades Of The Day, The Street, FreeRealTime, TraderPower, Marketbeat.com, Daily Trade Alert, 360 Wall Street, Premium Stock Alerts, DailyMarketAlerts, BillionDollarClub, PoliticsAndMyPortfolio, CryptoCurrencyWire, TopPennyStockMovers, Wall Street Mover, Kiplinger Today, FeedBlitz, Wealth Insider Alert, Investment House, The Wealth Report, StreetAuthority Daily, MarketClub Options, Eagle Financial Publications, DreamTeamNetwork, Trading Pub, TradingPub, Wealth Daily, Barchart, AllPennyStocks, DividendStocks, Inside Trading, Promotion Stock Secrets, Investment News Daily, Street Insider, StockOodles, Jeff Bishop, Lance Ippolito, Stock Beast, Stock Analyzer, Rick Saddler, RedChip, ProsperityPub and StreetInsider reported earlier on Marathon Digital Holdings Inc. (MARA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin (BTC) has seen little movement over the past few months. After a strong start to 2024, it has largely leveled off, trading between $56,000 and $62,000 since July. This stability contrasts sharply with the first half of the year, when the cryptocurrency jumped by 45%, largely fueled by U.S. spot ETFs.

Market watchers are now eager to see what might trigger a shift in Bitcoin’s performance. Most are paying close attention to key developments anticipated between December and early next year. Broader economic factors, such as changes in U.S. interest rates, are also seen as important. Traders are optimistic that the market may see a resurgence after the U.S. Securities and Exchange Commission (SEC) approved BlackRock’s new spot BTC ETF options.

Despite BTC’s potential, its volatility continues to be a key issue. In 2020, the 90-day volatility rate was 67%; it is already 42% this year. Analysts caution that in times of market volatility, BTC may be among the first assets to be liquidated because it is still strongly linked to the crypto market as a whole. For instance, growing Middle East tensions caused Bitcoin to fall by 5% last week.

Wintermute trader Jake Ostrovskis is upbeat about these options and believes more retail investors may be drawn to them. BIT Mining’s chief economist Youwei Yang notes, however, that more regulatory permits may be required, especially from the Commodity Futures Trading Commission (CFTC).

The Chainalysis Global Adoption Index tracks crypto usage in 151 countries. According to the index, adoption rates today are higher than they were during earlier cryptocurrency booms, especially in lower-income countries. Nations with restricted access to conventional banking institutions are where the use of cryptocurrencies is expanding the fastest.

India currently holds the top spot in the rankings, followed by Nigeria. Southeast Asian countries such as the Philippines, Indonesia and Vietnam also rank highly, as many people there are turning to crypto as an alternative to their currencies, which are often weakened by high inflation.

The value of Bitcoin is still high in these areas, according to Mauricio Di Bartolomeo of the cryptocurrency lending site Ledn. Many people in emerging markets choose to store their wealth in U.S. dollars due to a lack of trust in local financial institutions.

The U.S. ranks fourth worldwide in cryptocurrency adoption. South Korea and China take the 19th and 20th spots, respectively. The United States is the global leader in transaction volume, followed by India.

The next significant rise in BTC will be determined by a confluence of market trends, regulatory choices and rates of worldwide acceptance, all of which are important considerations for the crypto market.

It would also be insightful to track which emerging markets entities such as Marathon Digital Holdings Inc. (NASDAQ: MARA) expand their operations into the space, as this could provide indicators about where else this industry holds the greatest promise of massive growth.

Marathon Digital Holdings Inc. (MARA), closed Monday's trading session at $16.98, up 5.597%, on 65,860,574 volume. The average volume for the last 3 months is 282,535 and the stock's 52-week low/high is $7.625/$34.09.

Verano Holdings Corp. (VRNOF)

QualityStocks, MarketBeat, CannabisNewsWire, InvestorPlace, The Street, Earnings360, Early Bird and Cabot Wealth reported earlier on Verano Holdings Corp. (VRNOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New York authorities recently published a comprehensive report on the progress of the state’s cannabis legalization law, which was signed by former Governor Andrew Cuomo in 2021. The state’s cannabis management office (OCM) shared the document, outlining the advancements made toward achieving the law’s primary goals.

The outlined advancements include fostering equity and creating opportunities for groups that have been disproportionately impacted by marijuana prohibition, building a strong and thriving industry, and preserving the environment, among others.

Tremaine Wright, head of the state marijuana control board, stated, “This report demonstrates our dedication to transparency and equity. I’m proud of how far we’ve come in the last three years to create a strong foundation for New York’s marijuana industry. Our objective has always been establishing a just and equitable industry that addresses historical wrongs and forges ahead with new prospects.”

According to the report, the state has licensed 200 cannabis retail dispensaries, with more than 1,300 recreational cannabis business licenses issued in total. The report also noted that54.7% of the licenses have gone to applicants from economic and social equity backgrounds. Additionally, most cannabis users are now purchasing from legal sources. According to the report, 67% of consumers who used marijuana in the past year said they bought their products from licensed dispensaries.

Another significant result of the law is the expungement of marijuana-related criminal records. More than 200,000 convictions have already been sealed, while an additional 107,000 are awaiting the same process. Furthermore, the report confirms that no one in the state is currently incarcerated for marijuana-related offenses alone.

In terms of consumer habits, the report noted that as of 2022, 14.9% of New Yorkers 18 years of age and older used marijuana monthly, with 7% reporting daily use. In addition, 52% said they used cannabis for recreational purposes, while 13.5% were medical users. Meanwhile, 34.5% reported using cannabis for both medical and recreational purposes.

The enforcement section of the report emphasizes that enforcing cannabis laws is crucial to maintaining a level playing field for legal operators. The report highlights that enforcement protects the investments of legal entrepreneurs while holding those selling illegal and unsafe products accountable.

The report acknowledges the struggles faced during the market’s initial phase, such as delays in rolling out the market, leadership disputes and issues surrounding the cannabis social-equity fund. It states that there is still much to do, including refining data collection, improving customer service, educating consumers and tackling the illegal marijuana market. Nonetheless, the officials are upbeat about the potential success of the sector.

The progress that is being made in rolling out the adult-use marijuana program in New York State is being watched positively by the entire industry, including entities such as Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) that would like to see all adults who use marijuana obtaining it from a licensed source.

Verano Holdings Corp. (VRNOF), closed Monday's trading session at $3.36, up 5%, on 205,385 volume. The average volume for the last 3 months is 25.724M and the stock's 52-week low/high is $3.00/$7.08.

Snap Inc. (SNAP)

Schaeffer's, InvestorPlace, The Street, MarketClub Analysis, MarketBeat, StockEarnings, StocksEarning, Trades Of The Day, Kiplinger Today, Zacks, StreetInsider, Daily Trade Alert, Market Intelligence Center Alert, INO Market Report, The Online Investor, Investopedia, Wealth Insider Alert, QualityStocks, CNBC Breaking News, Early Bird, Barchart, The Street Report, Marketbeat.com, StockMarketWatch, Trading Concepts, StreetAuthority Daily, Profit Confidential, Louis Navellier, Top Pros' Top Picks, Market Intelligence Center, FreeRealTime, AllPennyStocks, Investors Alley, GorillaTrades, Daily Profit, Money Morning, Jon Markman’s Pivotal Point, TopStockAnalysts, Investment House, InvestmentHouse, Uncommon Wisdom, Total Wealth, Cabot Wealth, Trading Tips, 24/7 Trader, The Wealth Report, TipRanks, MarketTamer, Investiv, Investing Daily, Investment U, MarketWatch, Max Wealth, Energy & Resources Digest, Economy & Markets, Dynamic Wealth Report, Rick Saddler, SmallCap Network, StockGuru, Wall Street Window, wyatt research newsletter, Daily Wealth, Epic Stock Picks, Direction Alerts, BUYINS.NET, 360 Wall Street, Premium Stock Alerts, Wealth Week, Wealth Daily, Wall Street Profit Search, Wall Street Daily, Technology Profits Daily, StrategicTechInvestor, StockRockandRoll, Schaeffer’s, Promotion Stock Secrets, newmoneycrew, Prism MarketView, InvestorsObserver Team, Power Profit Trades, PennyStockLocks, Penny Stock 101, Penny Picks, OTC Stock Review, Money and Markets, MarketClub, Jon Markman's Pivotal Point, InvestorsUnderground and ProfitableTrading reported earlier on Snap Inc. (SNAP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Snap (NYSE: SNAP) owns and operates Snapchat, a popular multimedia messaging app known for its unique features like disappearing messages and augmented reality filters. The company is now shifting its advertising strategy by introducing ads to the app’s main Chat tab. This change aims to increase revenue by monetizing more areas of the platform.

Currently, SNAP’s stock price is $11, showing a decrease of 1.168% or $0.13. This fluctuation reflects the market’s reaction to Snapchat’s new advertising strategy. The stock has seen a low of $10.86 and a high of $11.20 today, indicating some volatility as investors assess the impact of this change.

Over the past year, SNAP’s stock has experienced significant highs and lows, with a peak of $17.90 and a low of $8.29. This range highlights the challenges and opportunities Snapchat faces in the competitive social media landscape. The company’s market capitalization is approximately $18.25 billion, showing its substantial presence in the industry.

Snapchat’s decision to introduce ads in the Chat tab is a strategic move to boost its revenue streams. With a trading volume of 12,003,214 shares, investor interest remains strong as the company explores new ways to monetize its platform. This development could influence SNAP’s stock performance in the coming months.

To view the company’s most recent earnings release, visit https://ibn.fm/I0aWg

About Snap Inc.

Snap is a technology company that believes the camera presents the greatest opportunity to improve the way people live and communicate. Snap contributes to human progress by empowering people to express themselves, live in the moment, learn about the world, and have fun together. For more information, visit the company’s website at www.Snap.com.

Snap Inc. (SNAP), closed Monday's trading session at $11.05, off by 0.7187781%, on 21,296,660 volume. The average volume for the last 3 months is 2.871M and the stock's 52-week low/high is $8.29/$17.90.

Nikola Corporation (NKLA)

Green Car Stocks, Schaeffer's, StockEarnings, InvestorPlace, QualityStocks, MarketClub Analysis, StocksEarning, MarketBeat, The Street, Early Bird, Kiplinger Today, Trades Of The Day, StreetInsider, Daily Trade Alert, The Online Investor, Zacks, GreenCarStocks, Cabot Wealth, Louis Navellier, CNBC Breaking News, Wealth Insider Alert, Investopedia, Premium Stock Alerts, MarketTamer, InvestorsUnderground, INO Market Report, BillionDollarClub, Prism MarketView, Daily Profit, Outsider Club, DividendStocks, TipRanks, Earnings360, The Wealth Report, Green Energy Stocks, AllPennyStocks, StockMarketWatch and Daily Wealth reported earlier on Nikola Corporation (NKLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nikola Corporation (NASDAQ: NKLA) is making moves in the electric truck world, and this time, it’s all about hydrogen. The company recently delivered 88 Class 8 hydrogen fuel cell trucks in the third quarter, which marks a 22% increase from the previous quarter. Even though it didn’t match the massive 80% surge it saw at the beginning of the year, Nikola is right on track. Investors have taken note of this, resulting in the company’s stock jumping by 9.5% after the announcement.

But before we get too excited, let’s keep in mind that Nikola’s stock has had a rough year. It’s down more than 82% so far. A big reason for this is the overall slowdown in the electric vehicle (EV) industry, with consumer demand softening across the board. That said, the jump in truck deliveries shows there’s still a solid market for Nikola’s hydrogen-powered rigs, which are proving to be hits with customers.

The Phoenix-based electric vehicle (EV) manufacturer’s shift to hydrogen-powered trucks is no accident. The company faced some major setbacks with its battery-electric trucks, including a massive recall in 2023 after fires caused by coolant leaks. For this reason, the company, whose mission is focused on zero-emissions transportation, decided to double down on hydrogen fuel cells, which have quickly become its star product.

It’s not hard to see why. Hydrogen fuel cells offer a few big advantages over battery-electric trucks, especially for long-haul freight. They can refuel much faster, and they provide more range, making them a strong contender for companies looking to ditch diesel. This shift in focus is helping Nikola rebuild trust after the battery-electric fiasco and keep its customers happy.

At the moment, the company has delivered 200 hydrogen trucks so far this year, with a goal of hitting 300 to 350 by year’s end. It’s not just a one-off, either — since launching its hydrogen trucks in the fourth quarter of 2023, Nikola has sold a total of 235 units. Clearly, this isn’t a fluke; customers like what they see.

The transition from battery-electric to hydrogen is a strategic move that is helping Nikola stay in the game. The hydrogen trucks are bringing in new customers and orders, giving the company a chance to prove that its technology can work on a larger scale.

While Nikola’s stock has plummeted this year, it’s not all bad news. Less than two months ago, the company surprised everyone by beating Wall Street’s revenue estimates for the second quarter. Even better, Nikola posted a smaller-than-expected loss. This isn’t so bad for a company that has experienced a lot.

In the coming months, it will be interesting to see if Nikola can maintain this momentum. For now, howeer, it looks like the company is starting to turn things around by focusing on hydrogen-powered vehicles.

Nikola Corporation (NKLA), closed Monday's trading session at $4.24, off by 1.3953%, on 1,686,740 volume. The average volume for the last 3 months is 33.725M and the stock's 52-week low/high is $4.10/$38.40.

Lucid Group (LCID)

Green Car Stocks, InvestorPlace, StockEarnings, Schaeffer's, QualityStocks, MarketClub Analysis, The Street, Early Bird, MarketBeat, GreenCarStocks, StocksEarning, Investopedia, INO Market Report, BillionDollarClub, Daily Trade Alert, Kiplinger Today, Trades Of The Day, Money Wealth Matters, The Online Investor, Premium Stock Alerts, The Wealth Report, Louis Navellier, DividendStocks, FreeRealTime, Green Energy Stocks, The Night Owl, Zacks, InsiderTrades, Smartmoneytrading, InvestorsUnderground, Earnings360, Top Pros’ Top Picks, 360 Wall Street, Cabot Wealth, Wealth Whisperer, AllPennyStocks and The Stock Dork reported earlier on Lucid Group (LCID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lucid Group (NASDAQ: LCID), maker of the world's most-advanced electric vehicles, is teaming up with Four Seasons hotels and resorts to offer complimentary cars for guest use at select locations. The collaboration begins this month and underscores the commitment both companies have for environmental stewardship as well as providing guests with flexible, unique, ecofriendly experiences during their stays. Guests can either reserve a Lucid vehicle for a complimentary driving experience or enjoy a chauffeured Lucid house car, based on availability.

In addition, Lucid is providing electric vehicle chargers, which are compatible with other electric vehicle types and will be available for both hotel guests and community members to conveniently charge their own vehicles. The program will begin this fall at select locations in the United States with additional properties in North America, Europe and the Middle East to be added in coming months.

“Every time guests step into a Lucid Air, they will be welcomed by a meticulously crafted interior, elegant design and a driving experience that is unmatched by any other vehicle on the road today,” said Lucid Group CEO Peter Rawlinson in the press release. “Through this partnership, the world's most advanced electric vehicle will now be available as a guest amenity, further enhancing the travel experience at Four Seasons properties across the globe.”

To view the full press release, visit https://ibn.fm/hkKwP

About Lucid Group Inc.

Lucid is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. Its flagship vehicle, Lucid Air Grand Touring, delivers best-in-class performance and world-leading range of up to 512 miles on a single charge. Lucid is preparing its state-of-the-art, vertically integrated factory in Arizona to begin production of the Lucid Gravity SUV. The company's goal is to accelerate humanity's transition to sustainable transportation and energy. For more information about the company, visit www.LucidMotors.com.

Lucid Group (LCID), closed Monday's trading session at $3.33, off by 2.0588%, on 17,062,843 volume. The average volume for the last 3 months is 925,518 and the stock's 52-week low/high is $2.29/$5.38.

Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, QualityStocks, MarketClub Analysis, StocksEarning, The Street, MarketBeat, Daily Trade Alert, Trades Of The Day, Wealth Insider Alert, The Online Investor, StockEarnings, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, BUYINS.NET, The Wealth Report, Zacks, CannabisNewsWire, Investopedia, Top Pros' Top Picks, Stock Up Featured, Cabot Wealth, InvestmentHouse, Daily Profit, Early Bird, Jim Cramer, InsiderTrades, The Rich Investor, InvestorsObserver Team, InvestorsUnderground, 24/7 Trader, Money Morning, VectorVest, Small Cap Firm, Stock Gumshoe, TheTradingReport and Wall Street Window reported earlier on Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A scientific review on cancer and cannabis has concluded that various cannabinoids, including cannabidiol (CBD), cannabigerol (CBG) and delta-9 tetrahydrocannabinol (THC), hold promising potential as anticancer agents via different mechanisms.

Already, clinical trials have shown the effectiveness of cannabinoids in health improvement and the regression of tumors in palliative care.

The review was carried out by a team of nine scientists from schools in Turkey, Pakistan, South Korea, Romania, Portugal and Saudi Arabia. The researchers examined studies on the anticancer properties of cannabinoids, which included review articles, research papers and meta-analyzes involving in vivo, clinical and in vitro trials.

Their analysis covered different types of cancer, including glioma, breast cancer, melanoma, lung and leukemia. The researchers also investigated the use of cannabis in palliative care and patients undergoing chemotherapy, discovering that cannabinoids play a huge role in palliative care because it helped regulate pain, nausea and the patients’ appetites.

The review also showed that cannabinoids may work together with chemotherapy, with the study suggesting that the compounds could enhance the treatment’s cytotoxic effects via different mechanisms.

For example, delta-9 THC and CBD demonstrated that they could decrease cell proliferation and cause apoptosis when administered in conjunction with chemotherapeutic agents such as paclitaxel and cisplatin. These cannabinoids could also modulate pathways involved in apoptosis and regulation of cell cycles, which helped increase cancer cell susceptibility to death induced by chemotherapy.

In their report, the researchers highlighted the huge gaps in knowledge regarding marijuana’s mode of action and effects on the microenvironment of tumors, among others. They also acknowledged that hurdles to incorporating marijuana into cancer treatment remained, including determining optimal dosing and regulatory barriers. In addition, the researchers emphasized the need for further randomized trials to validate their findings and noted that by improving the understanding of the mechanisms of cannabinoids and their interactions with cancer cells, they could better harness their therapeutic potential.

Results of the review were published in the “Discover Oncology” journal.

Publication comes just after a special issue focusing on marijuana and cancer was published by the “National Cancer Institute.” The special issue centered on answering questions around the relationship patients had with marijuana, including reasons for use, behavioral patterns linked to the use of marijuana, associated cost and sourcing of the drug.

Earlier in the year, another study on the potential therapeutic value of marijuana compounds determined that some minor cannabinoids may possess anticancer effects on leukemia. These findings were reported in the “BioFactors” journal.

Such studies could provide inspiration for cannabis companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) to develop products targeting patients with particular forms of cancer. These treatments could supplement the conventional treatments currently being used to manage various cancers.

Group Inc. (CRON), closed Monday's trading session at $2.2, off by 0.4524887%, on 422,936 volume. The average volume for the last 3 months is 310,730 and the stock's 52-week low/high is $1.70/$3.14.

The QualityStocks Company Corner

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe recently announced that courts in Australia and New Zealand have approved its SOBRsure(TM) technology for use in family law cases

The company entered the Australian and New Zealand markets earlier this year via an international channel partnership agreement with Drug Testing Business Success

The recent announcement also contained updates on the company's opportunity for international expansion across India and Italy

In India, SOBRsafe's SOBRcheck(TM) stationary alcohol detection device has been selected for a proof-of-concept installation at a public facility to screen employees

In Italy, a global employer has selected SOBRsafe's SOBRsure(TM) continuous alcohol monitoring wristband for proof-of-concept use by its fleet drivers

Early this year, SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, announced that the sale of its SOBRsure(TM) wearable continuous alcohol monitoring device had begun in Australia and New Zealand following a 90-day proof-of-concept. This overseas milestone was made possible through an international channel partnership with Drug Testing Business Success, the leading drug and alcohol testing service provider in the region (https://ibn.fm/3X0AI). .

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Monday's trading session at $6.79, up 3.6641%, on 24,366 volume. The average volume for the last 3 months is 1.049M and the stock's 52-week low/high is $3.70/$110.00.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today announced plans to establish Mullen Credit Corporation ("MCC") as its wholly owned subsidiary. According to the announcement, MCC will offer vehicle floor planning, enabling the company's growing dealership network to finance inventory upfront and repay the loan plus interest once the vehicle is sold. MCC will also provide fleet and small business customers with attractive financing options. "Our business is experiencing rapid growth, with projected sales for 2025 expected to increase significantly. Consequently, our financing needs have also evolved," said David Michery, Chairman and CEO. "Mullen Credit Corporation will provide financing flexibility for our dealers and customers as we pursue accelerated growth and expand our market share."

To view the full press release, visit https://ibn.fm/mRTDG

Factors such as high purchase costs, limited range and unreliable public charging infrastructure have consistently hindered electric vehicle (EV) adoption since Tesla unveiled the first mass-market electric car over a decade ago. As a result, stakeholders ranging from governments and car companies to battery makers are working on various innovative solutions to overcome the barriers to electric vehicle adoption. Such innovations will be key to ensuring the transportation sector, which generates roughly 30% of global greenhouse gas emissions, is electrified. Electrified roads have also emerged as an alternative and more convenient means of charging and a potential solution to range anxiety. This novel solution works by funneling energy to traveling EVs via three different means: inductive charging, overhead wires and conductive charging. These systems allow drivers to top their vehicles without having to stop and could go a long way toward alleviating range anxiety. When manufacturers such as Mullen Automotive Inc. (NASDAQ: MULN) incorporate a number of these innovations in their products and approaches, we could see the uptake of EVs accelerate in ways that would have seemed impossible given the current dip in the sales of these new energy vehicles.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $2.53, up 18.7793%, on 2,211,834 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $110.00/$.

Recent News

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

Longeveron (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, today announced that it will present a late breaking poster at the 17th edition of the Clinical Trials on Alzheimer's Disease Conference ("CTAD24"). The poster is titled "Lomecel-B inhibition of MMP14 activity predicts Lomecel-B bioactivity in the treatment of mild Alzheimer's disease." The conference is taking place in Madrid, Spain, from October 29, 2024, to November 1, 2024.

"We are excited to have been selected to present important Lomecel-B(TM) data at a leading forum for Alzheimer's research and clinical investigation," said Wa'el Hashad, CEO of Longeveron. "We believe the findings offer potential mechanistic and clinical insights in the development of cellular-based therapy for Alzheimer's disease."

To view the full press release, visit https://ibn.fm/057tq

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.

Lomecel-B™

Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306
Email: mmoyer@lifesciadvisors.com

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Monday's trading session at $1.94, up 8.3799%, on 591,550 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.7707/$23.90.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, announced Thursday morning that it has introduced service level agreements ("SLAs") to support Leap™ quantum cloud service customers as they move quantum applications into production. The formal SLAs represent D-Wave's commitment to providing high levels of availability, reliability and scalability for its Leap cloud service. According to the announcement, the Leap cloud service offers 99.9% uptime and availability and takes just a fraction of a second to process a job, even under heavy customer usage. In addition, the SLAs demonstrate the company's dedication to supporting requirements for commercial-grade quantum and hybrid-quantum applications as customers transition their applications into production.

"As the transition to production deployments accelerates, providing exceptional access to our cloud service has never been more critical," said Dr. Trevor Lanting, chief development officer of D-Wave. "Our SLA offering is designed to support this dynamic shift with confidence, enabling businesses to thrive as quantum technology's commercial value and adoption grows."

To view the full press release, visit https://ibn.fm/jVDoo

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $1.01, up 4.1237%, on 4,287,825 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.57/$2.44.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Costco began selling 1-ounce gold bars late last year. While this was restricted to members of Costco, analysts at Wells Fargo estimate that the popular retailer sells between $100 million to $200 million in gold bars monthly. Now members of Costco can also purchase one-ounce bars of platinum at $1089.99. Platinum's value has risen by 15% since last year, with its demand growing significantly. The silvery-white metal is resistant to corrosion, just like gold. It has many different uses, among them its use in catalytic converters for trucks, cars, and buses. This use makes up 50% of its annual demand. Platinum is effective at converting emissions produced from a car's engine into less harmful waste products. Any individual who's thinking about investing in precious metals should conduct their own research and examine the kind of value they'll be getting from these retailers. With gold and other precious metals now available to ordinary consumers at retailers like Costco, entities like Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) engaged in gold exploration and extraction can expect the market for their products to be even more massive than has been the case in recent times.

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Monday's trading session at $0.0791, up 10.9397%, on 3,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0364/$0.1164.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Astiva is a leading provider of personalized and comprehensive healthcare solutions to diverse communities. "Medicare open enrollment for 2024-2025 begins on Oct. 15, 2024, and closes on Dec. 7, 2024, as noted in a recent Medicare Advocates article… Astiva Health provides a standout option during this critical enrollment period, offering a health plan designed to meet the specialized needs of its members," a recent article reads. "A key feature of Astiva's plans is its unmatched rebates and grocery benefits. Members are eligible to receive the full Part B premium rebate of $174.70 monthly, helping to alleviate the financial burden of healthcare costs. Additionally, members benefit from a grocery allowance ranging from $100 to $135 per month – a valuable resource to help cover the rising costs of food… The company offers an extensive array of extra benefits, including transportation services for medical appointments, fitness programs, hearing and vision coverage, dental care and more." To view the full article, visit https://ibn.fm/suFZM

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

The QualityStocks Daily Newsletter would like to spotlight Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI).

The 20th century saw many advancements being adopted in the medical field, among them, potable water, penicillin and, most importantly, vaccines. Vaccines have saved millions of lives, from the eradication of smallpox globally in the 1980s to their use in curbing the spread of the coronavirus in 2020. Over the last 10 years, however, rates of vaccination have begun to drop, threatening the great beneficial effects of vaccinations not only in the United States but also around the globe. In their conclusion, the researchers voiced concerns associated with the recent emergence of a new strain of influenza in China. They also noted that achieving goals in vaccination to help eradicate various infectious illnesses required sustained collaboration. The review's findings were published in "The American Journal of Medicine." It is becoming increasingly vital to develop alternative ways to prevent infectious diseases from taking a huge toll on human health. Approaches such as the development of immunotherapies by companies such as Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) can help to treat those who are in critical need as these emerging and reemerging infectious diseases become widespread.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, Scinai is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. Scinai is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, Scinai has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, Scinai signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. Scinai anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of Scinai’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

Scinai has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, Scinai will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. Scinai anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

CDMO Services

While NanoAb pipeline development is Scinai’s core focus, the company also offers its cGMP manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for contract development and manufacturing organization (CDMO) services. This offering is designed to keep the Scinai team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb pipeline development.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future Scinai drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is Scinai’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at Scinai. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at Scinai. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining Scinai, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at Scinai. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to Scinai through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), closed Monday's trading session at $3.7, off by 2.6316%, on 5,783 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.23/$8.92.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

A recent UN General Assembly intergenerational panel titled ‘Mainstreaming Gender & Youth for SDG7: Challenges & Opportunities for Young Women Entering the Workforce' has called for the increased involvement of women and youth in the green energy transition. Convened by Sustainable Energy for All (SEforALL) at the ENERGY NOW SDG7 Action Forum on September 27th, the dynamic panel focused on the role young women are playing in the ongoing transition to renewable energy and outlined the need to close gender gaps and enable the youth to enter the energy industry. The global green energy industry is still in its infancy and is expected to balloon in size as the green transition accelerates. Shortlist's Ciara Remerscheid discussed the impact of initiatives such as Women for Green Jobs that increase access to jobs. Women for Green Jobs has created 565 new employment opportunities for women that only require minor credentials or some vocational training. It would be interesting to hear what suggestions entities like First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) engaged in the extraction of green energy minerals recommend regarding workable ways to engage more youth and women within this specific segment.

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Monday's trading session at $0.1015, off by 1.4563%, on 104,066 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.047785/$0.1245.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

Renforth Resources (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR), an active mineral exploration company engaged in the exploration and development of its wholly owned, multicommodity mineral properties located in Canada, is committed to helping meet the demand for minerals. "Among the projects the company is working on is its Malartic Metals Package Project, which is comprised of 540 mining claims, totaling more than 30,327 hectares, south of the town of Cadillac, Quebec. The project is contiguous to the Canadian Malartic Mine, the second-largest operating gold mine in Canada and one of the world's largest gold-mining operations," a recent article reads.

"The company's most recent update reflected mapping and prospecting work and noted that the project is known to ‘host several occurrences of nickel/cobalt/zinc/copper polymetallic mineralization over >29 km of strike as well as numerous pegmatites prospective for lithium, with elevated lithium also occurring in the Pontiac sediment host rock.' The update noted several highlights, including prospecting that showed two new locations of surface nickel polymetallic (nickel/cobalt/zinc/copper) mineralization, similar to that seen within the Victoria system."

To view the full article, visit https://ibn.fm/DDc8b

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Monday's trading session at $0.01045, off by 24.2754%, on 20,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0068/$0.0242.

Recent News

Energy and Water Development Corp. (OTCQB: EAWD)

The QualityStocks Daily Newsletter would like to spotlightFathom Energy and Water Development Corp. (OTCQB: EAWD) .

Currently, roughly 6% of all managed funds in Canada are termed as environmental, social and governance (ESG). In Europe, about 48% of assets under management are classified as sustainable funds, which is a labeling system almost completely similar to ESG. This disparity seems huge, but Baillie Gifford head of ESG, Catherine Flockhart, believes the quantity of funds and assets is only a fragment of the bigger picture. Flockhart explains that while Europe leads in the space when it comes to quantity, the level of sophistication exhibited by institutions in Canada, particularly when it comes to ESG strategy adoption, takes the cake. She argues that as sponsors and asset managers focused on increasing ESG allocations, they may benefit from evaluating the state of Canada's market on a quality metric. In addition, Flockhart acknowledges opportunities that ESG highlights, noting that asset managers often use ESG metrics to generate alpha and evaluate risk. In her conclusion, Flockhart explains that viewing ESG as a tool that can help managers better understand investments in portfolios allows the metric to be helpful instead of a distraction. Entities that are systematically integrating ESG within their operations, such as Energy and Water Development Corp. (OTCQB: EAWD), are actually taking a long-term term view of the benefits of these practices, and this ties in with what experts are recommending for those who wish to reap the gains that can result from adopting ESG.

Energy and Water Development Corp. (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water and energy systems out of already existing, proven technologies, utilizing its patent-pending systems configuration and technical know-how to customize solutions to meet clients’ needs. To date, two water systems have been sold and deployed in Mexico and Germany, and the company is working to fulfill additional orders.

Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany. The company is a United Nations-accredited vendor and offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations for the sustainable supply of energy and water.

EAWD focuses on three main aspects of the water and energy business: (1) generation, (2) supply and (3) maintenance. The green tech industry is constantly evolving due to ongoing and increasing water scarcity, as well as increased energy needs in the world. Therefore, the company believes that by designing sustainable and renewable solutions to these problems, EAWD will become an essential component of a rapidly growing industry with many new markets.

EAWD’s approach seeks to assist businesses with the growth and development of their general operations by ensuring the efficient, profitable and sustainable supply and generation of water and energy, allowing its potential customers to focus on their business while adopting strategies of sustainability.

By using the state-of-the-art technological solutions and technologies identified, designed and provided by EAWD and its collaborators, the company believes that its potential clients will be free to focus on the performance of their operations, as well as with the water and energy consumption or generation regulations within their industries.

EAWD is headquartered in Saint Petersburg, Florida, with operations in Germany and Mexico.

Products

In view of the increased worldwide demand for water and energy, EAWD’s business goals are focused on self-sufficient energy-supplied water generation and green energy production. To accomplish this, the company set out to establish an outsourcing green tech platform to commercialize its state-of-the-art technologies while providing engineering and technical consultation services to design the most sustainable technological solutions that can provide water and energy.

The company has sought potential collaboration with green tech research and development centers in Europe and has established its operating subsidiaries in Hamburg, Germany, where EAWD has started to assemble its patent-pending innovative off-grid, self-sufficient energy supply atmosphere water generation (AWG) systems.

EAWD Deutschland and EAWD Logistik operate in Hamburg, Germany, to meet the increasing demands of water and energy generation projects around the world, as well as to operate the solar-powered EAWD Off-Grid EV Charging Stations, EAWD’s newest product.

The company expects to offer sustainable added value to each project it takes on, while generating revenue from the sale of EAWD Off-Grid AWG Systems, EAWD Off-Grid EV Charging Stations, EAWD Off-Grid Power Systems and EAWD Off-Grid Water Purification Systems; royalties from the commercialization of energy and water in certain cases; and licensing of its innovated technologies, along with its engineering, technical consulting and project management services.

EAWD continues to be a development stage company. It presently assembles its EAWD Off-Grid AWG Systems and EAWD Off-Grid EV Charging Stations at its workshop in Germany and outsources most of its engineering and technical services, as well as services relating to the promotion, sale and distribution of its products.

Market Opportunity

According to a report by Allied Market Research, a global market research, consulting and advisory firm, the worldwide green technology and sustainability market was valued at $10.32 billion in 2020 and is projected to reach a value of $74.64 billion by 2030, growing at a CAGR of 21.9% during the forecast period.

A surge in environmental awareness and increasing concerns among organizations and individuals about climate change drive the growth of the market. Furthermore, an increase in consumer and industrial interest for the use of clean energy resources are among some of the major factors expected to boost growth of the market in the coming years, according to the report.

The expected rise in favorable government and private initiatives to tackle climate change and air pollution represent an opportunistic factor of the market. An increase in energy consumption and rise in greenhouse gas emissions are major factors that drive the development of green technology innovations, the report states.

Management Team

Irma Velazquez is CEO and Vice Chair at EAWD. She brings certified expertise in sustainable development and large-scale project management to the company. She formerly worked for United Nations agencies including the World Health Organization, Farmaciens Sans Frontieres, Red Cross and Crescent Societies, where she served in the positions of Information Technology Manager, Sustainable Development Manager, Programme Manager and Disaster and Crisis Management Coordinator. She has a master’s in sciences from the Erasmus University of Rotterdam. She speaks French, English and Spanish.

Ralph Hofmeier is Chief Technology Officer and Chairman at EAWD. He brings a mechanical engineering background to the company and previously served as President of Powermax Energy & Business Solutions Inc. When that company merged with EAWD, he served as President and CEO of Directors of EAWD. Over the last 20 years, he has established and developed several multinational companies in green tech distribution and commercialization. He speaks German and English.

Energy and Water Development Corp. (OTCQB: EAWD), closed Monday's trading session at $0.0034, off by 22.3744%, on 3,137,101 volume. The average volume for the last 3 months is 557,879 and the stock's 52-week low/high is $0.00305/$0.12.

Recent News

ECGI Holdings Inc. (OTC: ECGI)

The QualityStocks Daily Newsletter would like to spotlight ECGI Holdings Inc. (OTC: ECGI).

ECGI Holdings Inc. (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle.

Moving forward, ECGI Holdings is focused on identifying and capitalizing on growth opportunities that align with the company’s business objectives and continuing to improve its financial structure. In 2024, ECGI Holdings was approved by Evolve — a distinguished name in vacation rental management. This partnership will transform the company’s 40-acre Lake County property into a luxurious short-term rental destination aptly named Vintner’s Caldera Ranch.

ECGI Holdings is excited about the possibilities that Vintner’s Caldera Ranch creates for shareholders and looks forward to further developments poised to unlock the value of other underutilized assets. The company believes that it is laying a solid foundation for sustained success and profitability in the years to come.

ECGI Holdings is headquartered in Irvine, California.

Operational Philosophy

ECGI Holdings has embarked on an ambitious new vision and strategic direction to build and nurture luxury brands that resonate with its core values and market aspirations. Its joint venture with Pacific Saddlery epitomizes ECGI Holdings’ strategic shift toward luxury branding, leveraging Pacific Saddlery’s tangible and established market presence in equestrian products.

This transition will also allow ECGI Holdings to explore new pathways to monetize its underutilized assets, including the company’s vineyard. A key highlight of the company’s future outlook is the debut of Pacific Saddlery’s new mobile retail boutique at specific equestrian events in 2024. This innovative venture represents a significant step in ECGI Holdings’ strategy to enhance brand visibility and engage directly with the company’s target market.

In addition, the Vintner’s Caldera Ranch development marks a significant step in advancing the company’s strategy to revitalize and leverage underutilized assets. Vintner’s Caldera Ranch is set against the backdrop of Lake County’s breathtaking scenery, offering an exclusive getaway experience that blends natural beauty with luxury. Choosing Evolve is a strategic move to ensure that Vintner’s Caldera Ranch not only meets but exceeds the high standards of service that luxury guests expect.

Evolve’s expertise in maximizing rental potential and delivering exceptional guest experiences is crucial to the company’s vision of making Vintner’s Caldera Ranch a preferred choice for discerning travelers. With this venture, ECGI Holdings is not only expanding its footprint within the luxury rental marketplace, but also contributing to the local economy and enhancing the appeal of Lake County as a tourist destination.

The company’s focus remains steadfast on strategic growth, operational excellence and customer satisfaction.

Market Outlook

A report from Grand View Research, a global market research and consulting company, estimated the value of the worldwide luxury brands market at $366.23 billion in 2023 and projects the market to grow to a value of $580.43 billion by 2030, achieving a CAGR of 6.8% over the forecast period.

Rising disposable income and wealth in various regions of the world, particularly in emerging markets such as China and India, have propelled the growth of the market, according to the report.

Younger consumers, such as millennials and Generation Z, are increasingly entering the luxury market, driving demand for more contemporary and experiential luxury offerings. The rise of social media and influencer marketing has greatly impacted the visibility and desirability of luxury products, the report states.

Management Team

Jamie Steigerwald is CEO of ECGI Holdings, Inc. He is a successful entrepreneur with over 30 years of experience. Most recently, he was COO of Sugarmade Inc. (OTC: SGMD), a California cannabis real estate, cultivation, manufacturing and services company. He is the owner of SwiftLead, an Orange County web marketing, design and development company. He previously was COO for First USA Home Loans, a retail mortgage lender, and co-founder and President of SwiftLead Software, a mortgage lead tracking system.

Nick Collins is CEO at Pacific Saddlery. He brings over 25 years of expertise in equestrian luxury goods. He previously founded Rolling Meadows and created the Allon Equestrian and Renard et Cheval apparel brands. He was instrumental in creating and launching Kaval.com, an online equestrian apparel and accessories site.

ECGI Holdings Inc. (OTC: ECGI), closed Monday's trading session at $0.0018, even for the day. The average volume for the last 3 months is 187,062 and the stock's 52-week low/high is $0.0015/$0.0149.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Monday's trading session at $0.12325, up 6.5485%, on 4,011 volume. The average volume for the last 3 months is 74,717 and the stock's 52-week low/high is $0.061/$10.26.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.